Cetera Investment Advisers
BCDA icon

Cetera Investment Advisers’s BioCardia BCDA Stock Holding History

Cetera Investment Advisers’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,275
Closed -$39.5K – 4576
2025
Q2 		$39.5K Buy
+20,275
New +$45.1K ﹤0.01% 3987
2022
Q3 		– Sell
-841
Closed -$18K – 1743
2022
Q2 		$18K Buy
+841
New +$20.1K ﹤0.01% 1794

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cetera Investment Advisers's BCDA Position: Q3 2025 in Review

Cetera Investment Advisers sold out of BioCardia (BCDA) in Q3 2025, closing a stake of 20,275 shares — an estimated $39.5K sold.

Cetera Investment Advisers first reported a position in BCDA in Q2 2022 and held it in 2 quarters. The position peaked at $39.5K in Q2 2025. 18 funds tracked by Wall St. Rank hold BCDA as of Q3 2025.

  • Cetera Investment Advisers reported no remaining BioCardia position as of Q3 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 20,275 BioCardia shares in Q3 2025, an estimated $39.5K.
  • Cetera Investment Advisers first reported a position in BioCardia in Q2 2022 and held it in 2 quarters.
  • Cetera Investment Advisers's BioCardia position peaked at $39.5K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q3 2025.

Based on Cetera Investment Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.